The company's low P/S ratio may be due to poor revenue perfo...
The company's low P/S ratio may be due to poor revenue performance and expectations that this will continue, which could impact the future direction of the share price. The company's outlook for shrinking revenue is contributing to its low P/S. Given these circumstances, it's hard to see the share price rising strongly in the near future.
Investors Don't See Light At End Of Nanjing Vazyme Biotech Co.,Ltd's (SHSE:688105) Tunnel And Push Stock Down 27%
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment